Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables

May 27, 2015, 09:30 ET from ABMRG

SINGAPORE, LONDON and NEW YORK, May 27, 2015 /PRNewswire/ --

-http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html

- Over 70% Indonesian men (80 million) are chain smokers

- Around 400,000 Indonesians die annually due to smoking-related conditions; of these, 6% are passive smokers

- Three-fourths of 6.5 million vehicles in Jakarta do not pass the emission test

Indonesia is the fourth most populous country in the world with almost 5% of the total deaths triggered by respiratory diseases like Chronic Obstructive Pulmonary Disorder (COPD) and Asthma and Obstructive Sleep Apnea (OSA). The Indonesian respiratory device market is forecast to grow at a CAGR of 9% till 2020. The market comprises diagnostic devices such as spirometers and peak flow meters, monitoring devices such as capnographs and pulse oximeters; therapeutic devices such as oxygen concentrators and nebulisers; Continuous Positive Airway Pressure (CPAP) devices, and disposables such as oxygen masks, nasal cannulae and CPAP masks.

     (Logo: http://photos.prnewswire.com/prnh/20140502/685460)

The growth in Indonesia market is backed by a rise in smoking habits, increased air pollution, enhanced life expectancy, improved healthcare infrastructure and government initiatives. Though a considerable population of Indonesia is young, due to the rise in smoking habits accompanied by improved life expectancy, chances of developing COPD and other chronic respiratory diseases will rise considerably, which will increase the need for respiratory management and diagnostic devices like nebulisers, peak flow meters, CPAP and spirometers in the near future.

Jakarta is the largest and most polluted city in Indonesia and has the highest number of asthma cases. The air in Jakarta is highly polluted as most vehicles do not pass the emission test that has resulted in an increase in the number of asthma cases, especially in children and a resultant rise in demand for nebulisers. The demand for disposable devices has also increased due to a surge for disposables over reusable ones.  

Indonesia has a wide network of primary healthcare centres called Puskesmas with at least one Puskesma for every 30,000 people. All these centres need basic respiratory devices such as nebulisers, peak flow meters and pulse oximeters in order to provide better healthcare services to the patients. The government insurance programs like Jamkesmas and Universal Health Insurance Coverage to provide free basic healthcare services to all the citizens will also drive the market.

"The Indonesia market is underpenetrated and therefore offers attractive growth opportunities especially for foreign manufactures as it lacks domestic manufacturing facilities. However, low awareness and affordability may restrain the market growth to some extent," said Uday Sai Ranjan Avula, analyst at ABMRG.

Key players in Indonesian respiratory devices market are AirSep Corporation, a division of Chart Industries, CareFusion Corp, Covidien plc, DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare Corp Ltd, Invacare Corporation, Omron Healthcare, Inc., a division of Omron Corporation, Philips Respironics, Inc., a division of Koninklijke Philips N.V. and ResMed Inc.

'Indonesia Respiratory Devices and Respiratory Diagnostics Market through 2020 - Detailed analysis of Hospital and Retail market', a report recently published by ABMRG, reviews historical trends and forecasts (between 2007 and 2020), annualised sales - market size (value and units), market growth, pricing, competitive landscape and market share.

It offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines, product approvals and launches, recalls and litigations, market dynamics, market drivers and restrains.

Why one should buy this report  

The report can be instrumental in making strategic decisions pertaining to:

  • Make a business development strategy for the respiratory devices in Indonesia.
  • Frame a distribution strategy in Indonesia based on a detailed analysis of hospital and retail channel market.
  • Make capital investments based on the forecast for high potential market.
  • Identify in-licensing and out-licensing opportunities, and recognizing potential business partners and M&A targets within the respiratory devices market.
  • Get access to in-depth information and data relating to the Indonesia respiratory devices market.
  • Prepare management and strategic presentations for investors and shareholders.

Other strategic market reports:  

- ASEAN and Oceania Respiratory Devices and Diagnostics Market Through 2021

http://www.abmrg.com/ASEAN-and-Oceania-Respiratory-Devices-and-Diagnostics-Market-Through-2021.html

- North America Respiratory Disposable and Anesthesia Disposable Device Market - Growth Trends and Potential 2006-2019

http://www.abmrg.com/North-America-Respiratory-Disposable-Device-Market-Trends-and-Potential-2006-2019.html

About ABMRG 

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on medical technology and pharmaceuticals. It offers comprehensive research and analytical studies targeting company, country and therapeutic sector, highlighting market dynamics, vital trends, business strategies, clinical pipeline and technology advancements. Its cutting edge reports empower companies to make smarter, effective and faster strategic decisions for business growth.

Contact:
Ankit Jian
sales@abmrg.com ; 19@abmrg.com
+91-8238155239; +91-261-2216406

SOURCE ABMRG